Research Papers

25 of 52 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
RAS-expanded Mutations and HER2 Expression in Metastatic Colorectal Cancer: A New Step of Precision Medicine.
Valentini AM; Cavalcanti E; Di Maggio M; Caruso ML.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2018
1/6 Transparent
Analysis of MTR and MTRR Gene Polymorphisms in Chinese Patients With Ventricular Septal Defect.
Su J; Li Z.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melano…
Phillips T; Millett MM; Zhang X; Jansson M; Cleveland R; Simmons P; Cherryholmes G; Carnahan J; William J; Spaulding B; Satnick IR; Inzunza HD; Taylor C; Cogswell J; Novotny J; Oroudjev E; Winther H.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2018
1/6 Transparent
Funding Declared
Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and …
Georgescu R; Boros M; Moncea D; Bauer O; Coros MF; Oprea A; Moldovan C; Podoleanu C; Stolnicu S.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Usage of DNA Fingerprinting Technology for Quality Control in Molecular Lab Bench Work.
McIntosh LY; Lal JE; Qin D.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2018
1/6 Transparent
New MYC IHC Classifier Integrating Quantitative Architecture Parameters to Predict MYC Gene Translocation in Diffuse La…
Bigras G; Dong WF; Canil S; Lai R; Morel D; Swanson PE; Izevbaye I.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2018
2/6 Transparent
Code
Precision Medicine Starts With Preanalytics: Real-Time Assessment of Tissue Fixation Quality by Ultrasound Time-of-Flig…
Lerch ML; Bauer DR; Chafin D; Theiss A; Otter M; Baird GS.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Digital Image Analysis of HER2 Immunostained Gastric and Gastroesophageal Junction Adenocarcinomas.
Nielsen SL; Nielsen S; Vyberg M.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2017
1/6 Transparent
Detecting Gene Rearrangements in Patient Populations Through a 2-Step Diagnostic Test Comprised of Rapid IHC Enrichment…
Murphy DA; Ely HA; Shoemaker R; Boomer A; Culver BP; Hoskins I; Haimes JD; Walters RD; Fernandez D; Stahl JA; Lee J; Kim KM; Lamoureux J; Christiansen J.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2017
1/6 Transparent
The Potential Diagnostic Utility of TROP-2 in Thyroid Neoplasms.
Liu H; Shi J; Lin F.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2017
1/6 Transparent
Immunohistochemical Performance of Estrogen and Progesterone Receptor Antibodies on the Dako Omnis Staining Platform: E…
Hicks D; Dell'Orto P; Falzon M; Hoff KD; Levy YY; McMahon L; Miller K; Russo L; Viale G.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Human Papillomavirus (HPV) Detection in Cytologic Specimens: Similarities and Differences of Available Methodology.
Bihl MP; Tornillo L; Kind AB; Obermann E; Noppen C; Chaffard R; Wynne P; Grilli B; Foerster A; Terracciano LM; Hoeller S.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2017
1/6 Transparent
Optimized Protocol of Methanol Treatment for Immunofluorescent Staining in Fixed Brain Slices.
Yuan F; Xiong G; Cohen NA; Cohen AS.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2017
1/6 Transparent
Association Between Phosphorylated Histone H3 and Oncotype DX Recurrence Scores in Breast Cancer.
Lee LH; Swanson PE; Tang PA; Bigras G; Yang H.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays: Erratum.
NA
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2016
Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer.
Agrawal A; Ziolkowski P; Grzebieniak Z; Jelen M; Bobinski P; Agrawal S.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2016
1/6 Transparent
Modeling Canadian Quality Control Test Program for Steroid Hormone Receptors in Breast Cancer: Diagnostic Accuracy Stud…
Pérez T; Makrestsov N; Garatt J; Torlakovic E; Gilks CB; Mallett S.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
A Dual Color Immunohistochemistry Assay for Measurement of Cereblon in Multiple Myeloma Patient Samples.
Ren Y; Wang M; Couto S; Hansel DE; Miller K; Lopez-Girona A; Bjorklund CC; Gandhi AK; Thakurta A; Chopra R; Breider M.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2016
1/6 Transparent
Her-2 Expression in Gastroesophageal Intestinal Metaplasia, Dysplasia, and Adenocarcinoma.
Almhanna K; Rosa M; Henderson-Jackson E; Jiang K; Shamekh R; Sayegh Z; Malafa MP; Coppola D.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Image-guided Coring for Large-scale Studies in Molecular Pathology.
Montaser-Kouhsari L; Knoblauch NW; Oh EY; Baker G; Christensen S; Hazra A; Tamimi RM; Beck AH.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Decline in Antigenicity of Tumor Markers by Storage Time Using Pathology Sections Cut From Tissue Microarrays.
Blows FM; Ali HR; Dawson SJ; Le Quesne J; Provenzano E; Caldas C; Pharoah PD.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Development of an automated PD-L1 immunohistochemistry (IHC) assay for non-small cell lung cancer.
Phillips T; Simmons P; Inzunza HD; Cogswell J; Novotny J; Taylor C; Zhang X.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2015
2/6 Transparent
Funding Declared
A Pilot Study of Galectin-3, HBME-1, and p27 Triple Immunostaining Pattern for Diagnosis of Indeterminate Thyroid Nodul…
Zhang L; Krausz T; DeMay RM.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2015
1/6 Transparent
Overexpression of β3 Chains of Laminin-332 is Associated With Clinicopathologic Features and Decreased Survival in Pati…
Chen J; Wang W; Wei J; Zhou D; Zhao X; Song W; Sun Q; Huang P; Zheng S.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2015
1/6 Transparent
Specific genomic aberrations predict survival, but low mutation rate in cancer hot spots, in clear cell renal cell carc…
Köhn L; Svenson U; Ljungberg B; Roos G.
Appl Immunohistochem Mol Morphol (Unknown)
Published: 2015
3/6 Transparent
Data Funding Declared